Dual amylin/calcitonin receptor agonist - Metsera
Latest Information Update: 02 May 2024
At a glance
- Originator Metsera
- Class Obesity therapies
- Mechanism of Action Amylin receptor agonists; Calcitonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Metabolic disorders; Obesity